Next Article in Journal
Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study
Next Article in Special Issue
Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics
Previous Article in Journal
Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles
Previous Article in Special Issue
DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways
 
 
Article

Article Versions Notes

Pharmaceutics 2018, 10(4), 196; https://doi.org/10.3390/pharmaceutics10040196
Action Date Notes Link
article html file updated 21 October 2018 05:45 CEST Original file -
article xml file uploaded 21 October 2018 05:45 CEST Original file -
article xml uploaded. 21 October 2018 05:45 CEST Update -
article pdf uploaded. 21 October 2018 05:45 CEST Version of Record https://www.mdpi.com/1999-4923/10/4/196/pdf-vor
article supplementary file uploaded. 21 October 2018 05:45 CEST - https://www.mdpi.com/1999-4923/10/4/196#supplementary
article html file updated 24 October 2018 05:59 CEST Update -
article xml file uploaded 24 October 2018 05:59 CEST Update -
article xml uploaded. 24 October 2018 05:59 CEST Update https://www.mdpi.com/1999-4923/10/4/196/xml
article pdf uploaded. 24 October 2018 05:59 CEST Updated version of record https://www.mdpi.com/1999-4923/10/4/196/pdf
article supplementary file uploaded. 24 October 2018 05:59 CEST - https://www.mdpi.com/1999-4923/10/4/196#supplementary
article html file updated 1 April 2019 09:35 CEST Update -
article html file updated 14 April 2019 12:46 CEST Update -
article html file updated 28 April 2019 17:36 CEST Update -
article html file updated 9 October 2019 09:02 CEST Update -
article html file updated 10 February 2020 17:06 CET Update -
article html file updated 17 July 2022 05:36 CEST Update https://www.mdpi.com/1999-4923/10/4/196/html
Back to TopTop